Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-04-06 Sale | 2023-04-10 6:20 pm | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner | 60,000 | $17.32 | $1,039,200 | 8,840,750 (Indirect Direct) | View |
| 2023-01-04 Sale | 2023-01-06 8:00 pm | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner | 60,000 | $22.01 | $1,320,876 | 9,280,639 (Indirect Direct) | View |
| 2022-11-10 Sale | 2022-11-14 8:00 pm | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner | 60,000 | $15 | $900,000 | 9,407,300 (Indirect Direct) | View |
| 2021-06-25 Sale | 2021-06-29 5:23 pm | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director | 473,250 | $30.83 | $14,589,493 | 8,546,750 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-04-06 Exercise | 2023-04-10 6:20 pm | N/A 2027-08-23 | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner | 60,000 | $0 | 8,840,750 (Direct) | View |
| 2023-04-06 Exercise | 2023-04-10 6:20 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner | 60,000 | $0.41 | 8,840,750 (Direct) | View |
| 2022-11-15 Ownership | 2023-02-14 4:44 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director | 436,646 | $0 | 8,546,750 (Indirect) | View |
| 2023-01-04 Exercise | 2023-01-06 8:00 pm | N/A 2027-08-23 | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner | 60,000 | $0 | 9,280,639 (Direct) | View |
| 2023-01-04 Exercise | 2023-01-06 8:00 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner | 60,000 | $0.41 | 9,280,639 (Direct) | View |
| 2022-11-10 Exercise | 2022-11-14 8:00 pm | N/A 2027-08-23 | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner | 60,000 | $0 | 9,407,300 (Direct) | View |
| 2022-11-10 Exercise | 2022-11-14 8:00 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner | 60,000 | $0.41 | 9,407,300 (Direct) | View |
| 2021-04-06 Ownership | 2022-02-14 5:37 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director | 233,227 | $0 | 8,546,750 (Indirect) | View |
| 2020-07-24 Ownership | 2021-02-16 5:28 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director | 265,150 | $0 | 9,021,000 (Direct) | View |
Ownership | 2021-02-16 5:28 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director | 0 | $0 | 9,021,000 (Indirect) | View |
| 2019-04-01 Gift | 2021-02-16 5:26 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director | 1,000 | $0 | 9,340,000 (Direct) | View |
| 2020-07-24 Other | 2021-02-16 5:26 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director | 240,000 | $60.76 | 9,340,000 (Indirect) | View |
| 2020-02-24 Disposition | 2020-05-13 7:21 pm | N/A N/A | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director 10% Owner | 300,000 | $30.08 | 9,181,000 (Indirect) | View |
| 2020-01-02 Option Award | 2020-04-28 4:47 pm | N/A 2030-01-02 | BioXcel Therapeutics Inc. | BTAI | Nandabalan Krishnan Director | 15,000 | $0 | 15,000 (Direct) | View |